Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis: A Systematic Review and Meta-Analysis
Rheumatology and Therapy · 2026-06 · 13 (3) · 545-562
DOI: 10.1007/s40744-026-00851-4 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Rheumatology and Therapy, online erschienen am 17.04.2026. Verfasst von Xingyun Wan und 5 weiteren Autor:innen. Beteiligte Einrichtung: Boao Shu Lan Hospital, Qionghai, China. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Boao Shu Lan Hospital, Qionghai, China.
- Department of Nephrology, First Medical Center of Chinese PLA General Hospital, State Key Laboratory of Kidney Diseases, National Clinical Research Center for Kidney Diseases, Beijing Key Laboratory of Medical Devices a…
- Department of Critical Care Medicine, First Medical Center of Chinese, PLA General Hospital, Fuxing Road No. 28, Beijing, China. chaoliu301@foxmail.com.
Zitieren
APA
Wan, X., Wang, X., Liang, S., Wang, Q., Liu, C., & Dong, Z. (2026). Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis: A Systematic Review and Meta-Analysis. Rheumatology and Therapy, 13(3), 545-562. https://doi.org/10.1007/s40744-026-00851-4
Vancouver
Wan X, Wang X, Liang S, Wang Q, Liu C, Dong Z. Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis: A Systematic Review and Meta-Analysis. Rheumatology and Therapy. 2026;13(3):545-562. doi:10.1007/s40744-026-00851-4
BibTeX
@article{Wan2026,
author = {Wan, Xingyun and Wang, Xiaolong and Liang, Shuang and Wang, Qian and Liu, Chao and Dong, Zheyi},
title = {Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis: A Systematic Review and Meta-Analysis},
journal = {Rheumatology and Therapy},
year = {2026},
volume = {13},
number = {3},
pages = {545--562},
doi = {10.1007/s40744-026-00851-4}
}
EUVIMED